Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 943 across all filing types
Latest filing 2025-08-12 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper advertisement about a special window for re-lodgement of transfer requests of physical shares. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, specifically Regulation 47, which pertains to disclosures and advertisements. The content is about informing the exchanges about the publication of a newspaper advertisement and includes copies of the advertisement. There is no financial data, no report attached or referenced as being published, no management discussion, no earnings data, no voting results, no capital changes, or any other financial or regulatory filing content. The document is essentially an announcement of a regulatory compliance advertisement publication. It is not a report itself but an announcement related to a regulatory requirement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2025-08-12 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates by a shareholder. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and issuance of confirmation letters. The content is about notifying the exchange of this event for record-keeping. There is no financial data, no report attached or referenced, no management or board changes, no voting results, no earnings or capital updates. This is a regulatory compliance notification related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It is an intimation under SEBI regulations about participation in investor meetings, without any financial data, detailed analysis, or report content. The document length is only 1447 characters, indicating it is a brief announcement rather than a full report or transcript. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2025-08-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings call for the quarter ended June 30, 2025, conducted on July 31, 2025. It includes detailed financial results, management commentary, and a Q&A session with analysts. The text explicitly mentions it is the "Q1FY26 Earnings Conference Call" transcript. The presence of detailed financial figures, management discussion, and Q&A confirms this is a full call transcript rather than a brief earnings release or summary. Therefore, the document fits the category of a Call Transcript (CT).
2025-08-04 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and NSE India) regarding the publication of the company's financial results for the quarter ended June 30, 2025. It mentions Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document includes copies of newspaper advertisements of the financial results, not the full financial report itself. The text is about informing the exchanges about the advertisement publication for the quarterly financial results, not the detailed financial statements or analysis. The document length is 15,000 characters, but the content is primarily an announcement of the publication of financial results in newspapers, not the results themselves. Therefore, this is an announcement related to financial results publication, fitting the category of Regulatory Filings (RNS) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2025-08-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges providing a link to the audio recordings of an earnings call for the quarter ended June 30, 2025. It references the earnings call but does not contain the transcript or detailed financial data itself. The document length is short (1117 characters) and serves as an announcement of the availability of the earnings call recording. According to the classification rules, such announcements about earnings calls are best classified as Call Transcript (CT) if they contain the transcript, but since this is only a notification with a link to the audio recording and no transcript, it is not a transcript itself. However, the closest relevant category is Call Transcript (CT) because it relates directly to the earnings call content. Confidence is high as the document explicitly mentions the earnings call and provides the recording link.
2025-07-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.